Results for this period
Third quarter1 October 2025 to 30 June 2026Non-consolidated (standalone)Japanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Revenue in the Healthcare Solutions Business declined because there were no deliveries this fiscal year of the large-scale ancillary department systems for electronic medical record systems delivered in the same period of the previous year. Revenue in the Global Environment Solutions Business declined because, although orders for PIX4Dcloud and other products remained firm, the transition to term-based licenses following price increases for PIX4Dmatic and other products, together with the failure to secure new orders for visible and near-infrared spectroradiometers, had an adverse impact.
A description of significant events, etc. is included. The company recognizes that operating losses have continued since the fiscal year ended September 2019 and that events or circumstances exist that raise significant doubt about the going-concern assumption, but has determined that no significant uncertainty is recognized at present. There are no applicable notes regarding the going-concern assumption.
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Non-consolidated (standalone) |
| Period Covered | 1 October 2025 to 30 June 2026 |
| Net Sales | ¥433 million (YoY -41.2%) |
| Operating profit | ¥-386 million |
| Ordinary income | ¥-509 million |
| Profit attributable to owners of the parent | ¥-377 million |
| Net income per share | (¥26.64) |
| Equity ratio | End of the current fiscal period 54 / End of previous period 48.9 |
| Total assets | ¥1,591 million |
| Net assets | ¥895 million |
| Cash and cash equivalents at end of period | ¥620,694 thousand |
| Full-year earnings forecast | Net Sales ¥580 million (YoY -33.0%) / Operating profit ¥-736 million / Ordinary income ¥-860 million / Net income ¥-728 million |
| Revision to Earnings Forecast | Net Sales Not disclosed → ¥580 million / Operating profit Not disclosed → ¥-736 million / Ordinary income Not disclosed → ¥-860 million / Net income Not disclosed → ¥-728 million |
| Annual Dividend Forecast | ¥0.00 → ¥0.00 |
| Segment revenue | Segment Healthcare Solutions business / Net Sales ¥335,675 thousand / Year-on-year (%) ¥-41 thousand, Segment Global Environment Solutions Business / Net Sales ¥98,177 thousand / Year-on-year (%) ¥-41.8 thousand |
| Segment profit | Segment Healthcare Solutions business / Segment profit ¥-84,351 thousand / Year on year against the same period last year Not disclosed, Segment Global Environment Solutions Business / Segment profit ¥-23,496 thousand / Year on year against the same period last year Not disclosed |
| Depreciation and amortization | ¥2,170 thousand |
| Impairment loss | ¥349 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Item Gain on contract cancellations / Amount ¥1,284 thousand, Item Gain on business transfer / Amount ¥149,999 thousand / Extraordinary loss Item Impairment Losses / Amount ¥349 thousand, Item Loss on Disposal of Fixed Assets / Amount ¥3,120 thousand, Item Contract cancellation losses / Amount ¥770 thousand, Item Litigation expenses / Amount ¥2,715 thousand, Item Settlement Payments / Amount ¥9,000 thousand |
| Disclosure regarding the going concern assumption | A description of significant events, etc. is included. The company recognizes that operating losses have continued since the fiscal year ended September 2019 and that events or circumstances exist that raise significant doubt about the going-concern assumption, but has determined that no significant uncertainty is recognized at present. There are no applicable notes regarding the going-concern assumption. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | Additions: 株式会社ENERGY SKIN JAPAN, 2nd SKIN LABS Inc., and 株式会社プリズム・メディカル. Exclusions: Not disclosed. The company plans to transition to consolidated financial reporting from the fourth quarter. |
| Material subsequent events | 株式会社ENERGY SKIN JAPAN was established on 1 July 2026, and the company plans to transition to consolidated financial reporting from the fourth quarter. 2nd SKIN LABS Inc. became a subsidiary through the acceptance of a third-party allotment of shares, with an acquired voting rights ratio of 51.0% and acquisition consideration of ¥180,478 thousand. 株式会社プリズム・メディカル became a subsidiary through the acquisition of shares, with an acquired voting rights ratio of 100%. The business combination date for both transactions is scheduled for 30 September 2026. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 15,191,900 shares |
| Treasury Shares at Period-End | 74,538 shares |
| Factors Behind Changes in Business Performance | Revenue in the Healthcare Solutions Business declined because there were no deliveries this fiscal year of the large-scale ancillary department systems for electronic medical record systems delivered in the same period of the previous year. Revenue in the Global Environment Solutions Business declined because, although orders for PIX4Dcloud and other products remained firm, the transition to term-based licenses following price increases for PIX4Dmatic and other products, together with the failure to secure new orders for visible and near-infrared spectroradiometers, had an adverse impact. |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Healthcare Solutions Business, there were no deliveries this fiscal year of the large-scale electronic medical records-related projects delivered in the same period of the previous year. In the Global Environment Solutions Business, revenue declined because the transition to term-based licenses following price increases and the acquisition of new orders for visible and near-infrared spectroradiometers did not materialize. For details of the reasons for revising the earnings forecast, the disclosure states that readers should refer to the separately released notice titled “Notice Regarding the Recording of Extraordinary Losses and Revision of the Full-Year Earnings Forecast.”